Selective removal of human serum amyloid P component from rat blood by use of an immunoaffinity membrane in an extracorporeal circulation system

被引:8
作者
Adachi, T [1 ]
Mogi, M [1 ]
Harada, M [1 ]
Kojima, K [1 ]
机构
[1] MATSUMOTO DENT COLL,DEPT ORAL BIOCHEM,NAGANO 39907,JAPAN
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1996年 / 682卷 / 01期
关键词
amyloid P;
D O I
10.1016/0378-4347(96)00059-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We examined the suitability of an immunoaffinity membrane (IAM) bearing specific antibody as a ligand for removing human serum amyloid P component (hSAP) from blood passed through a simple extracorporeal circulation system established in rats. The specific antibody was the most effective of the various ligands tested for removing hSAP from human blood, To determine the value of the hSAP in human or rat plasma, we also developed a simple ELISA. In the rat extracorporeal circulation system, the hSAP level in the inlet blood to the IAM module decreased to 49% of the initial concentration within 60 min. In contrast, the hSAP remained at the initial concentration throughout the study in the module without the IAM. The use of this extracorporeal circulation system in this case allows preclinical evaluation of the ex vivo removal of a human plasma component in an animal model. Biocompatibility of the IAM was also examined. No change in blood cell counts or activation of the coagulation system occurred after contact with the IAM. Non-specific adsorption was not observed, since there was no statistically significant difference in IgG, complement C3, or albumin level between the pre- and post-treatment with this module. The immunological effects of the IAM were also examined using this system. Four weeks after the termination of the extracorporeal circulation, the rats examined showed no detectable antibody titer to the ligand.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 20 条
[1]   SELECTIVE REMOVAL OF IMMUNOGLOBULIN-E FROM RAT-BLOOD BY MEMBRANE-IMMOBILIZED ANTIBODY [J].
ADACHI, T ;
MOGI, M ;
HARADA, M ;
KOJIMA, K .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1995, 668 (02) :327-332
[2]  
BALTZ ML, 1986, CLIN EXP IMMUNOL, V66, P691
[3]   MEASUREMENT OF NANOGRAM QUANTITIES OF PROTEIN BY HYDROLYSIS FOLLOWED BY REACTION WITH ORTHOPHTHALALDEHYDE OR DETERMINATION OF GLUTAMATE [J].
BUTCHER, EC ;
LOWRY, OH .
ANALYTICAL BIOCHEMISTRY, 1976, 76 (02) :502-523
[4]  
CHEUNG AK, 1994, NEPHROL DIAL TRANSPL, V9, P72
[5]  
CORIA F, 1988, LAB INVEST, V58, P454
[6]   STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID-P COMPONENT [J].
EMSLEY, J ;
WHITE, HE ;
OHARA, BP ;
OLIVA, G ;
SRINIVASAN, N ;
TICKLE, IJ ;
BLUNDELL, TL ;
PEPYS, MB ;
WOOD, SP .
NATURE, 1994, 367 (6461) :338-345
[7]   ANIMAL-MODELS FOR REACTIVE AMYLOIDOSIS [J].
GRUYS, E ;
SNEL, FWJJ .
BAILLIERES CLINICAL RHEUMATOLOGY, 1994, 8 (03) :599-611
[8]  
HIND CRK, 1984, LANCET, V2, P376
[9]  
Klinkmann H., 1987, UREMIA THERAPY, P125, DOI 10.1007/978-3-642-72720-7_10
[10]   SELECTIVE REMOVAL OF BETA-2-MICROGLOBULIN FROM HUMAN-PLASMA BY HIGH-PERFORMANCE IMMUNOAFFINITY CHROMATOGRAPHY [J].
MOGI, M ;
HARADA, M ;
ADACHI, T ;
KOJIMA, K ;
NAGATSU, T .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 496 (01) :194-200